Read + Share
Amedeo Smart
Independent Medical Education
Gane EJ, Dunbar PR, Brooks AE, Zhang F, et al. Safety and efficacy of the oral TLR8 agonist selgantolimod in individuals with chronic hepatitis B under viral suppression. J Hepatol 2023;78:513-523.PMID: 38133554
Email
LinkedIn
Facebook
Twitter
Privacy Policy